Clinical Trial Information Request for Protocol 22-173 Title A PHASE 1A/1B STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF STK-012 AS A SINGLE AGENT AND IN COMBINATION THERAPY IN SUBJECTS WITH SELECTED ADVANCED SOLID TUMORS PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone